These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1398245)

  • 1. Increased intestinal permeability in ankylosing spondylitis.
    Mielants H; Veys EM; De Vos M; Cuvelier C
    Gut; 1992 Aug; 33(8):1150. PubMed ID: 1398245
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of intestinal permeability in ankylosing spondylarthritis with a test using Cr-EDTA].
    Wendling D; Bidet A; Guidet M
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):29-32. PubMed ID: 2108485
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a functional index for patients with ankylosing spondylitis.
    Dougados M; Gueguen A; Nakache JP; Nguyen M; Amor B
    J Rheumatol; 1990 Sep; 17(9):1254-5. PubMed ID: 2290177
    [No Abstract]   [Full Text] [Related]  

  • 5. Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings.
    Orchard T; Jewell DP
    Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():10-5; discussion 15-6. PubMed ID: 9467974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankylosing spondylitis.
    Chee MM; Sturrock RD
    Scott Med J; 2007 Nov; 52(4):32-5; quiz 35, 54. PubMed ID: 18092635
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ankylosing spondylitis].
    Mitsui H
    Ryoikibetsu Shokogun Shirizu; 2000; (32):514-7. PubMed ID: 11212789
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenge of early diagnosis in ankylosing spondylitis.
    O'Shea F; Salonen D; Inman R
    J Rheumatol; 2007 Jan; 34(1):5-7. PubMed ID: 17216671
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoricoxib and the treatment of ankylosing spondylitis.
    Lories RJ
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1599-608. PubMed ID: 23126318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.
    Vaile JH; Meddings JB; Yacyshyn BR; Russell AS; Maksymowych WP
    J Rheumatol; 1999 Jan; 26(1):128-35. PubMed ID: 9918253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ankylosing spondylitis.
    Braun J; Sieper J
    Lancet; 2007 Apr; 369(9570):1379-1390. PubMed ID: 17448825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.
    Imrich R; Rovensky J; Zlnay M; Radikova Z; Macho L; Vigas M; Koska J
    Ann Rheum Dis; 2004 Jun; 63(6):671-4. PubMed ID: 15140773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of refractory spondylarthropathies].
    Dubost JJ; Soubrier M; Sauvezie B
    Presse Med; 1998 Jan; 27(4):175-80. PubMed ID: 9768034
    [No Abstract]   [Full Text] [Related]  

  • 16. [A rare cause of chronic diarrhea].
    Gatel A; Cacoub P; Sbaï A; Benhamou Y; Bellanger J; Godeau P; Piette JC
    Rev Med Interne; 1997; 18 Suppl 3():288s-290s. PubMed ID: 9239384
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing seronegative spondarthritides.
    Koehler L; Kuipers JG; Zeidler H
    Rheumatology (Oxford); 2000 Apr; 39(4):360-8. PubMed ID: 10817767
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of ankylosing and non-ankylosing spondylitis.
    Donnelly P
    Ir Med J; 1993; 86(6):175-6. PubMed ID: 8106217
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
    Hendrix S; Koenig A; Li W; Singh A
    J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ankylosing spondylitis].
    Komiya S
    Nihon Rinsho; 2005 May; 63 Suppl 5():365-9. PubMed ID: 15954377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.